Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: A retrospective analysis of 34 patients

References

• Lam KY, Lo CY. Metastatic tumours of the adrenal glands: A 30-year experience in a teaching hospital. Clin Endocrinol (Oxf) 2002;56:95–101.
   PubMed Web of Science ®Google Scholar
• Mayo-Smith WW, Boland GW, Noto RB, Lee MJ. State-of-the-art adrenal imaging. Radiographics 2001;21:995–1012.
   PubMed Web of Science ®Google Scholar
• Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, . 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004;45:2058–62.
   PubMed Web of Science ®Google Scholar
• Kim SH, Brennan MF, Russo P, Burt ME, Coit DG. The role of surgery in the treatment of clinically isolated adrenal metastasis Cancer 1998;82:389–94.
   Google Scholar
• Uberoi J, Munver R. Surgical management of metastases to the adrenal gland: Open, laparoscopic, and ablative approaches. Curr Urol Rep 2009;10:67–72.
   PubMedGoogle Scholar
• Sarela AI, Murphy I, Coit DG, Conlon KC. Metastasis to the adrenal gland: The emerging role of laparoscopic surgery. Ann Surg Oncol 2003;10:1191–6.
   PubMed Web of Science ®Google Scholar
• Duh QY. Laparoscopic adrenalectomy for isolated adrenal metastasis: The right thing to do and the right way to do it. Ann Surg Oncol 2007;14:3288–9.
   PubMedGoogle Scholar
• Hawksworth J, Geisinger K, Zagoria R, Kavanagh P, Howerton R, Levine EA, . Surgical and ablative treatment for metastatic adenocarcinoma to the liver from unknown primary tumor. Am Surg 2004;70:512–7.
   PubMedGoogle Scholar
• Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S. Curative treatment of stage I non-small-cell lung cancer in patients with severe COPD: Stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys Epub 2011 Jun 1.
   Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, . for the European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205–16.
   PubMed Web of Science ®Google Scholar
• Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, . Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677–82.
   PubMed Web of Science ®Google Scholar
• Norihisa Y, Nagata Y, Takayama K, Matsuo Y, Sakamoto T, Sakamoto M, . Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008;72:398–403.
   PubMed Web of Science ®Google Scholar
• Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, . Tolerance of organs at risk in small volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003;56:126–35.
   PubMed Web of Science ®Google Scholar
• Rubin P, Brasacchio R, Katz A. Solitary metastases: Illusion versus reality. Semin Radiat Oncol 2006;16:120–30.
   PubMed Web of Science ®Google Scholar
• Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol 2006;16:77–84.
   PubMed Web of Science ®Google Scholar
• Duh QY. Resecting isolated adrenal metastasis: Why and how? Ann Surg Oncol 2003;10:1138–9.
   PubMedGoogle Scholar
• Chawla S, Chen Y, Katz AW, Muhs AG, Philip A, Okunieff P, . Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys 2009;75:71–5.
   PubMed Web of Science ®Google Scholar
• Oshiro Y, Takeda Y, Hirano S, Ito H, Aruga T. Role of radiotherapy for local control of asymptomatic adrenal metastasis from lung cancer. Am J Clin Oncol 2011;34:249–53.
   PubMed Web of Science ®Google Scholar
• Holy R, Piroth M, Pinkawa M, Eble MJ. Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer. Strahlenther Onkol 2011;187:245–51.
   PubMed Web of Science ®Google Scholar
• Torok J, Wegner RE, Burton SA, Heron DE. Stereotactic body radiation therapy for adrenal metastases: A retrospective review of a noninvasive therapeutic strategy. Future Oncol 2011;7:145–51.
   PubMedGoogle Scholar
• Casamassima F, Livi L, Masciullo S, Menichelli C, Masi L, Meattini I, et al. Stereotactic radiotherapy for adrenal gland metastases: University of Florence experience. Int J Radiat Oncol Biol Phys Epub 2011 Feb 5.
   Google Scholar
• Scorsetti M, Mancosu P, Navarria P, Tozzi A, Castiglioni S, Clerici E, . Stereotactic body radiation therapy (SBRT) for adrenal metastases: A feasibility study of advanced techniques with modulated photons and protons. Strahlenther Onkol 2011;187:238–44.
   PubMedGoogle Scholar
• Zhang J, Yang F, Li B, Li H, Liu J, Huang W, . Which is the optimal biologically effective dose of stereotactic body radiotherapy for stage I non-small-cell lung cancer? A meta-analysis. Int J Radiat Oncol Biol Phys 2011;81:e305–16.
   PubMed Web of Science ®Google Scholar